Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 6, 2012, Pages 646-650

  Stepanova, Maria ^a,b   Younossi, Zobair M ^a,b  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

Author keywords

Heart Disease; Liver Disease; Obesity; Population Study

Indexed keywords

LIVER ENZYME;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; FOLLOW UP; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONALCOHOLIC FATTY LIVER; PREDICTOR VARIABLE; PREVALENCE; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84861329163     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.12.039     Document Type: Article

References (22)

1. Targher G., Bertolini L., Poli F., et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005, 54:3541-3546.
2. Lin Y.C., Lo H.M., Chen J.D. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 2005, 11:4838-4842.
3. Targher G., Bertolini L., Padovani R., et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29:1325-1330.
4. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007, 24:1-6.
5. Lizardi-Cervera J., Aguilar-Zapata D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol 2009, 8(Suppl 1):S40-S43.
6. Villanova N., Moscatiello S., Ramilli S., et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005, 42:473-480.
7. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
8. Targher G., Marra F., Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 2008, 51:1947-1953.
9. Hamaguchi M., Kojima T., Takeda N., et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007, 13:1579-1584.
10. Rafiq N., Bai C., Fang Y., et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009, 7:234-238.
11. Stepanova M., Rafiq N., Younossi Z.M. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010, 59:1410-1415.
12. Dunn W., Xu R., Wingard D.L., et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008, 103:2263-2271.
13. Stepanova M., Younossi Z.M. Association of chronic liver diseases and cardiovascular mortality-the authors' reply. Gut 2011 Feb 15, [Epub ahead of print].
14. Musso G., Gambino R., Cassader M., et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2010 Nov 2, [Epub ahead of print].
15. Calori G., Lattuada G., Ragogna F., et al. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011, 54:145-152.
16. NHANES 1988-1994: Hepatic/Gallbladder Ultrasound and Hepatic Steatosis Data Documentation, Codebook, and Frequencies. Available at: Accessed August 18, 2011. http://www.cdc.gov/nchs/nhanes/nhanes3/HGUHS.htm.
17. Analytic and reporting guidelines: the Third National Health and Nutrition Examination Survey, NHANES III (1988-94) 1996, CDC/NCHS, Hyattsville, MD.
18. Perseghin G. The role of non-alcoholic fatty liver disease in cardiovascular disease. Dig Dis 2010, 28:210-213.
19. Sung K.C., Ryan M.C., Wilson A.M. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2009, 203:581-586.
20. Maurantonio M., Ballestri S., Odoardi M.R., et al. Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk?. Arch Med Res 2011 Aug 12, [Epub ahead of print].
21. Bugianesi E. Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: another piece of the puzzle. Hepatology 2008, 47:2-4.
22. Younossi Z.M., Stepanova M., Afendy M., et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011, 9:524-530.e1.